Agonistic tumor necrosis factor (TNF) receptor binding agents | Patent Number 10927181

US 10927181 B2
Application Number16582534
Publication NumberUS 20200079866 A1
Pendency1 year, 5 months, 2 days
Filled DateSep 25, 2019
Priority DateJan 8, 2016
Publication DateMar 12, 2020
Expiration DateJan 7, 2036
Inventor/ApplicantsDavid Satijn
Ugur Sahin
Friederike Gieseke
Isil Altintas
Paul Parren
ExaminesLANDSMAN, ROBERT S
Art Unit1647
Technology Center1600
Assignments
Biontech Ag
Current
Genmab As
Original
Biontech Ag
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.